These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 23835004)
21. [Osteoporosis]. Uelbelhart B; Rizzoli R Rev Med Suisse; 2012 Jan; 8(324):109-10, 112-5. PubMed ID: 23185820 [TBL] [Abstract][Full Text] [Related]
22. Denosumab for postmenopausal osteoporosis? Drug Ther Bull; 2012 Jan; 50(1):6-8. PubMed ID: 22241889 [TBL] [Abstract][Full Text] [Related]
23. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. Wensel TM; Iranikhah MM; Wilborn TW Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432 [TBL] [Abstract][Full Text] [Related]
24. [Is SSBT associated with atypical femoral fracture? SSBT isn't associated with atypical femoral fracture]. Soen S Clin Calcium; 2012 Jun; 22(6):919-22. PubMed ID: 22653034 [TBL] [Abstract][Full Text] [Related]
25. Denosumab associated with bone density increase and clinical improvement in a long-term hemodialysis patient. Case report and review of the literature. Dusilova Sulkova S; Horacek J; Safranek R; Gorun P; Viklicky O; Palicka V Acta Medica (Hradec Kralove); 2014; 57(1):30-3. PubMed ID: 25006661 [TBL] [Abstract][Full Text] [Related]
26. Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy. Rachner TD; Platzbecker U; Felsenberg D; Hofbauer LC Mayo Clin Proc; 2013 Apr; 88(4):418-9. PubMed ID: 23541016 [TBL] [Abstract][Full Text] [Related]
27. Denosumab (prolia) for postmenopausal osteoporosis. Med Lett Drugs Ther; 2010 Oct; 52(1349):81-2. PubMed ID: 21045756 [No Abstract] [Full Text] [Related]
28. Preliminary success with combination treatment for osteoporosis. BMJ; 2013 May; 346():f3221. PubMed ID: 23699634 [No Abstract] [Full Text] [Related]
30. Denosumab in postmenopausal women with low bone mineral density. Schwartzman J; Yazici Y N Engl J Med; 2006 Jun; 354(22):2390-1; author reply 2390-1. PubMed ID: 16738280 [No Abstract] [Full Text] [Related]
31. Atypical Femur Fractures Associated With Diphosphonate Use - The Author Replies. Balach T J Am Acad Orthop Surg; 2016 Jan; 24(1):e20. PubMed ID: 27081687 [No Abstract] [Full Text] [Related]
33. Bisphosphonates and atypical femoral fractures: a time for reflection. Compston JE Maturitas; 2010 Jan; 65(1):3-4. PubMed ID: 19932574 [No Abstract] [Full Text] [Related]
34. [Diphosphonate treatment of osteoporosis and risk of atypical femoral fractures]. Schwarz P Ugeskr Laeger; 2012 Jan; 174(1-2):30. PubMed ID: 22233716 [No Abstract] [Full Text] [Related]
36. Denosumab, osteoporosis, and prevention of fractures. Blythe SL N Engl J Med; 2009 Nov; 361(22):2189-90; author reply 2190-1. PubMed ID: 19950410 [No Abstract] [Full Text] [Related]
37. Clinical use of denosumab for the treatment for postmenopausal osteoporosis. Lewiecki EM Curr Med Res Opin; 2010 Dec; 26(12):2807-12. PubMed ID: 21050058 [TBL] [Abstract][Full Text] [Related]
38. Denosumab, osteoporosis, and prevention of fractures. Blackwood J N Engl J Med; 2009 Nov; 361(22):2189; author reply 2190-1. PubMed ID: 19950411 [No Abstract] [Full Text] [Related]
39. Atypical insufficiency type femoral stress fractures in patient on bisphosphonates. Evangelista PT; Levine SM Med Health R I; 2012 Feb; 95(2):61-2. PubMed ID: 22474880 [No Abstract] [Full Text] [Related]
40. Denosumab and bone metastases. No better than a bisphosphonate. Prescrire Int; 2012 Sep; 21(130):204-6. PubMed ID: 23016249 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]